Berenberg Bank Cuts Johnson Matthey (LON:JMAT) Price Target to GBX 1,500

Johnson Matthey (LON:JMATFree Report) had its price objective lowered by Berenberg Bank from GBX 1,650 ($20.96) to GBX 1,500 ($19.05) in a research note published on Thursday morning, Marketbeat.com reports. The firm currently has a hold rating on the stock.

Johnson Matthey Price Performance

Johnson Matthey stock opened at GBX 1,359 ($17.26) on Thursday. Johnson Matthey has a 1 year low of GBX 1,318 ($16.74) and a 1 year high of GBX 1,917.07 ($24.35). The company has a debt-to-equity ratio of 63.15, a quick ratio of 0.76 and a current ratio of 1.45. The firm has a 50 day moving average price of GBX 1,505.05 and a 200 day moving average price of GBX 1,606.59. The company has a market cap of £2.37 billion, a price-to-earnings ratio of 2,343.10, a PEG ratio of 49,242.50 and a beta of 0.95.

Johnson Matthey Cuts Dividend

The company also recently declared a dividend, which will be paid on Tuesday, February 4th. Shareholders of record on Thursday, December 5th will be given a dividend of GBX 22 ($0.28) per share. This represents a yield of 1.47%. The ex-dividend date of this dividend is Thursday, December 5th. Johnson Matthey’s dividend payout ratio (DPR) is presently 13,275.86%.

Insider Transactions at Johnson Matthey

In other news, insider Stephen Oxley bought 7,407 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The stock was acquired at an average cost of GBX 1,343 ($17.06) per share, for a total transaction of £99,476.01 ($126,350.83). Also, insider Liam Condon purchased 27 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were purchased at an average cost of GBX 1,505 ($19.12) per share, for a total transaction of £406.35 ($516.13). Insiders have bought a total of 7,479 shares of company stock worth $10,057,890 in the last three months. 0.61% of the stock is currently owned by company insiders.

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.